$BMRN News Biotech comeback stalls as Wall Street

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2014 at 7:19 PM

$BMRN News

Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Major U.S. benchmarks pull in to first support 12:27 p.m. March 10, 2014 - Michael Ashbaugh
BioMarin shares rally as FDA mutes criticism of rare disorder drug 6:25 p.m. Nov. 15, 2013 - Russ Britt
German DAX ends at record as Europe stocks rally 12:10 p.m. Sept. 19, 2013 - Sara Sjolin
BioMarin rallies 7.6% on Roche takeover report 6:30 a.m. Sept. 19, 2013 - Sara Sjolin
S&P 500 retests the 50-day moving average 11:07 a.m. Sept. 9, 2013 - Michael Ashbaugh
Biotech ETF's breakout: bullish for stocks overall? 1:11 p.m. Sept. 5, 2013 - blogs.marketwatch.com
Acura, BioMarin mount independent rallies on their own positive news 3:28 p.m. July 1, 2013 - Russ Britt
After the close: Biogen slips, Epizyme slows, BioMarin stalls 5:57 p.m. June 4, 2013 - Russ Britt
Lofty expectations hit BioMarin in development of new cancer drugs 12:56 p.m. June 3, 2013 - Russ Britt
Get out of junk stocks now 1:14 p.m. March 22, 2013 - Mark Hulbert
Charting a slow-motion test of the 2012 peak 12:39 p.m. Jan. 11, 2013 - Michael Ashbaugh
U.S. benchmarks sustain the 2013 breakout 1:00 p.m. Jan. 4, 2013 - Michael Ashbaugh
Meet the S&P 500’s new range 12:17 p.m. Dec. 13, 2012 - Michael Ashbaugh
Charting a lackluster recovery attempt 12:49 p.m. Nov. 21, 2012 - Michael Ashbaugh
‘Aggressive’ comment hits Express Scripts 7:03 p.m. Nov. 5, 2012 - Russ Britt
BioMarin's GALNS meets primary endpoint in trial 10:24 a.m. Nov. 5, 2012 - MarketWatch.com
Biomarin says trial results meet primary endpoint 8:23 a.m. Nov. 5, 2012 - Greg Morcroft
Biomarin says its GALNS Phase III trial posiitve 8:23 a.m. Nov. 5, 2012 - Greg Morcroft
Staking out major support 10:46 a.m. Oct. 3, 2012 - Michael Ashbaugh

Insider Trading Alert - TWO, CCL And BMRN Traded By Insiders 10:30 a.m. Today - TheStreet.com
Drugs Stocks On The Rise With Help From 3 Stocks 1:02 p.m. June 3, 2014 - TheStreet.com
BioMarin's Pipeline Advances - Analyst Blog 11:40 a.m. May 29, 2014 - Zacks.com
The Trader Daily 7:30 a.m. May 29, 2014 - RealMoney.com
A Tale of Diversification 2:00 p.m. May 19, 2014 - RealMoney.com
Top Biotech Stocks for Cancer Cures from Cowen 8:08 a.m. May 16, 2014 - 247WallSt.com
Insider Trading Alert - WMGI, MSM And BMRN Traded By Insiders 10:30 a.m. May 14, 2014 - TheStreet.com
'Mad Money' Lightning Round: BioMarin Is for Real 6:00 a.m. May 8, 2014 - TheStreet.com
Cramer's Lightning Round - BioMarin Is A Biotech Survivor (5/7/14) 4:29 a.m. May 8, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: A Market Divided 8:12 p.m. May 7, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARIA SGEN BMRN ARNA 8:45 a.m. May 5, 2014 - InvestorPlace.com
BioMarin Pharmaceutical Inc. (BMRN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. May 5, 2014 - Zacks.com
Loss at BioMarin Narrower Than Expected - Analyst Blog 4:00 p.m. May 2, 2014 - Zacks.com
10-Q: BIOMARIN PHARMACEUTICAL INC 12:18 p.m. May 2, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioMarin Pharmaceutical's CEO Discusses Q1 2014 Results - Earnings Call Transcript 12:50 a.m. May 2, 2014 - Seeking Alpha
More on Biomarin Q1 results 5:18 p.m. May 1, 2014 - Seeking Alpha
Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock 4:27 p.m. May 1, 2014 - TheStreet.com
Notable earnings after Thursday close 5:35 p.m. April 30, 2014 - Seeking Alpha
EC approves Vimizim 11:48 a.m. April 28, 2014 - Seeking Alpha
Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases 8:48 a.m. April 23, 2014 - Seeking Alpha

Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF
BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease 8:02 a.m. May 27, 2014 - GlobeNewswire
Prestigious Recognitions, Product Enhancements, and Earnings Releases - Analyst Notes on Discover, BlackRock, Covance, BioMarin and Vertex 8:29 a.m. May 7, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
BioMarin to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference on May 14th and the UBS Global Healthcare Conference on May 20th 8:02 a.m. May 6, 2014 - GlobeNewswire
BioMarin Announces First Quarter 2014 Financial Results and VIMIZIM(TM) Launch Progress 4:06 p.m. May 1, 2014 - GlobeNewswire
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
BioMarin Announces European Commission Approval for VIMIZIM(R) (elosulfase alfa) for the Treatment of Morquio A Syndrome in Patients of All Ages 11:08 a.m. April 28, 2014 - GlobeNewswire
Earnings Schedules, Acquisition Agreements, and Financial Results Release - Analyst Notes on Mallinckrodt, BioMarin, Salix Pharmaceuticals, St. Jude Medical and Quest Diagnostics 8:00 a.m. April 25, 2014 - PR Newswire - PRF
BioMarin to Host First Quarter 2014 Financial Results Conference Call and Webcast on Thursday, May 1 at 5:00 p.m. ET 8:02 a.m. April 16, 2014 - GlobeNewswire
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin Pharma, Vertex Pharma, and Spectrum Pharma 11:15 a.m. April 15, 2014 - PR Newswire - PRF
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Extends Market Exclusivity Six Months for BioMarin's Rare Disease Therapy KUVAN(R) (sapropterin dihydrochloride) Powder for Oral Solution and Tablets 8:02 a.m. April 14, 2014 - GlobeNewswire
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Biotech Stocks Technical Review -- Research on BioCryst Pharma, Spectrum Pharma, BioMarin Pharma, and Vertex Pharma 11:55 a.m. March 26, 2014 - PR Newswire - PRF
BioMarin Appoints Pioneer in Personalized Medicine, Dennis J. Slamon, M.D., Ph.D., to Board of Directors 8:01 a.m. March 21, 2014 - GlobeNewswire
Critical Alerts For Voxeljet, QUALCOMM, Canadian Solar, NQ Mobile, and BioMarin Pharmaceuticals Released By InvestorsObserver 9:31 a.m. March 19, 2014 - PR Newswire - PRF
Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update 8:16 a.m. March 19, 2014 - GlobeNewswire
BioMarin Announces Pricing of Public Offering of Common Stock 9:00 a.m. March 5, 2014 - GlobeNewswire
BioMarin Announces Public Offering of Common Stock 5:22 p.m. March 4, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

OlloBot's Emotional AI Robots Connect Beyond Tasks

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Abbott's SonicForce Impresses in Crucial Clinical Trial

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Navigating Underinsured Motorist Coverage Woes

When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...

Dutch Bros Pours Holiday Cheer with New Festive Menu

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

Termite Swarmers: Essential Clues and Action Steps

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Brigham Nurses Dig In for Strike: Fight for Fairness

Strike Looms as Brigham Nurses Demand Fair Treatment Massachusetts is gearing up for its largest open-ended nursing strike in history as Brigham and Women's Hospital nurses prepare to lay down their tools in pursuit of a just contract. This ain't your typical workplace squabble; it's a full-blown battle for patient safety and professional respect. The Core Grievances at...

Perion Acquisition: Affle's Bold Leap in Ad Tech

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Aiper’s Black Friday Pool Deals Make a Splash

Black Friday: A Pool Owner's Break It’s not every day you stumble upon savings like these—Aiper is throwing some meaty discounts this Black Friday, saving pool owners up to a juicy $550 off robotic cleaners. Imagine that! For anyone with a pool to maintain, these deals might just be the ticket to less grunt work and more time lounging with a cold drink in hand....

SICO Snags $1.6B in New Investor Mandates for 2026

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...